Journal of Global Infectious DiseasesOfficial Publishing of INDUSEM and OPUS 12 Foundation, Inc. Users online:448  
Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size     
Home About us Editors Ahead of Print Current Issue Archives Search Instructions Subscribe Advertise Login 
 


 
   Table of Contents     
MICROBIOLOGY REPORT  
Year : 2015  |  Volume : 7  |  Issue : 3  |  Page : 113-115
Antibiotic resistance pattern of uropathogens: An experience from north Indian cancer patient


1 Department of Laboratory Medicine, Delhi State Cancer Institute, Delhi, India
2 Department of Clinical Oncology, Delhi State Cancer Institute, Delhi, India

Click here for correspondence address and email

Date of Web Publication18-Aug-2015
 

   Abstract 

Empirical treatment of urinary tract infections (UTIs) can be made evidence based if it is governed by the resistance pattern of common uropathogens. A retrospective study was carried out at a tertiary care cancer institute to identify the common uropathogens and to know their resistance profile. 20.82% of the outpatients' urine samples (community-acquired urinary tract infection (CA-UTI)) and 24.83% of the indoor patients' urine samples (hospital-acquired urinary tract infection (HA-UTI)) grew uropathogens. Escherichia coli was the predominant pathogen both in CA-UTI (68%) and HA-UTI (45%) followed by Klebsiella spp and Enterococcus spp. High level of resistance to fluoroquinolones and third generation cephalosporins was noted. Nitrofurantoin was found to be a reliable oral drug for treatment of most of the uropathogens.

Keywords: Antibiotic resistance, Community acquired, Hospital acquired, Urinary tract infection, Uropathogens

How to cite this article:
Ahmed NH, Raghuraman K, Baruah FK, Grover RK. Antibiotic resistance pattern of uropathogens: An experience from north Indian cancer patient. J Global Infect Dis 2015;7:113-5

How to cite this URL:
Ahmed NH, Raghuraman K, Baruah FK, Grover RK. Antibiotic resistance pattern of uropathogens: An experience from north Indian cancer patient. J Global Infect Dis [serial online] 2015 [cited 2019 Oct 15];7:113-5. Available from: http://www.jgid.org/text.asp?2015/7/3/113/161742



   Introduction Top


Urinary tract infections (UTIs) are the most commonly encountered infections in medical practice. [1] It is a major public health problem with an estimated 150 million cases per annum worldwide and with a financial burden of over 6 billion US dollar. [2] About 35% of all the UTIs are of nosocomial origin. [3] Most of the UTIs are treated empirically, the criteria for the selection of antimicrobial agent should be determined on the basis of the most likely pathogen and its expected resistance pattern in a geographical area. [4] Knowledge of infection epidemiology and the institutional resistance pattern can help physicians to select the optimal empirical treatment in critically-ill patients. [5] This retrospective study was designed to know the antibiotic resistance pattern of the uropathogens and to suggest an appropriate empirical treatment.


   Microbiology Report Top


It was a retrospective study carried out at a tertiary care cancer institute. Patient records were assigned into two categories. The first group comprising of urine samples from patients admitted in the hospital for at least 48 h (hospital-acquired UTI (HA-UTI)) and the second group from patients visiting the hospital on outpatient basis or admitted less than 48 h (community-acquired-UTI (CA-UTI)). Records of 13 months (15/7/2013-15/8/2014), of patients having UTI were studied and the uropathogens were recognized. Nonfermenters isolated were confirmed with repeat sample and were recorded when the same isolate with similar antibiotic susceptibility pattern was seen. Identification and antibiotic susceptibility of the bacterial pathogens was done using VITEK ® 2 Compact (C) system version: 06.01 (Biomeriux, North Carolina, USA). Antibiotic susceptibility results were expressed according to the Clinical Laboratory Standards Institute M100-S23 (2013). [6]

Statistical analysis was done using Fisher's exact test.

The study involved a total of 1,530 consecutive urine samples, over a period of 13 months. A total of 1,028 (67.19%) samples were from suspected CA-UTI patients, of which 214 (20.82%) grew uropathogens. Four hundred and two (26.27%) samples were from suspected HA-UTI patients of which 98 (24.38%) grew uropathogens.

Gram negative bacilli accounted for 194 (90.65%), gram positive cocci for 12 (5.6%), and Candida spp for eight (3.74%) of the CA-UTI. Among the HA-UTI, 54 (55.10%) were gram negative bacilli, 18 (18.37%) were gram positive cocci, and 13 (13.27%) were Candida species.

[Table 1] shows the uropathogens isolated from CA-UTI and HA-UTI patients.
Table 1: Frequency, percentage, and P-value of resistance of uropathogens isolated from CA-UTI versus HA-UTI patients

Click here to view


Escherichia coli was the predominant pathogen both in CA-UTI (68%) and HA-UTI (45%) followed by Klebsiella spp (18% in CA-UTI and 24% in HA-UTI) and Enterococcus spp (6% in CA-UTI and 21% in HA-UTI).

Among Escherichia coli, resistance to piperacillin tazobactum, third generation cephalosporins, carbapenems, ciprofloxacin, ampicillin, amoxycillin-clavulinic acid, and cefepime was more significantly associated with HA-UTI than CA-UTI [Table 1]. A comparison of resistance pattern of HA-UTI and CA-UTI among uropathogenic Escherichia coli from various studies in India is shown in [Table 2]. In case of Klebsiella spp and Enterobacter spp, resistance to piperacillin tazobactum; third generation cephalosporins, carbapenem, gentamicin, amikacin, ciprofloxacin, cefepime, trimethoprim, and sulfamethoxazole were more significantly associated with HA-UTI than CA-UTI [Table 1].
Table 2: Comparison of resistance pattern ofHA-UTI and CA-UTI amonguropathogenic Escherichia coli from various studies in India

Click here to view


Among nonfermenters, 80% isolates were resistant to aztreonam in HA-UTI compared to 25% of the isolates being resistant to aztreonam in CA-UTI. 25% of isolates were resistant to piperacillin tazobactumin CA-UTI when compared to 60% in HA-UTI.

None of the Enterococcus spp isolated in CA-UTI was resistant to nitrofurantoin compared to 28% of resistant isolates in HA-UTI.


   Conclusion Top


Our data indicates that Escherichia coli is still the most frequent uropathogen, both in HA-UTI and CA-UTI. Ampicillin, cefuroxime, ceftriaxone, nalidixic acid, ciprofloxacin, and cotrimoxazole did not have good in vitro coverage for many of the uropathogens in this study. High level resistance against fluoroquinolones and third generation cephalosporins is a matter of concern, especially in CA-UTI where these are the drugs of choice. This could be due to indiscriminate use and availability of over-the-counter antibiotics. Nitrofurantoin still remains the best oral drug for treatment of most of the uropathogens. Updates on the knowledge of antibiotic resistance pattern of uropathogens is important for timely modifying the drugs of choice for empirical therapy which is required for early and effective treatment of the infection. [12]

 
   References Top

1.
Ahmed NH, Hussain T, Biswal I. Comparison of etiological agents and resistance patterns of the pathogens causing community acquired and hospital acquired urinary tract infections. J Glob Infect Dis 2014;6:135-6.  Back to cited text no. 1
    
2.
Gonzalez CM, Schaeffer AJ. Treatment of urinary tract infection: What′s old, what′s new, and what works. World J Urol 1999;17:372-82.  Back to cited text no. 2
    
3.
Mishra MP, Debata NK, Padhy RN. Surveillance of multidrug resistant uropathogenic bacteria in hospitalized patients in Indian. Asian Pac J Trop Biomed 2013;3:315-24.  Back to cited text no. 3
    
4.
Alabi AS, Frielinghaus L, Kaba H, Koster K, Huson MA, Kahl BC, et al. Retrospective analysis of antimicrobial resistance and bacterial spectrum of infectionin Gabon, Central Africa. BMC Infect Dis 2013;13:455.  Back to cited text no. 4
    
5.
Jeena J, Debata NK, Subhudi E. Prevalence of extended-spectrum-beta-lactamase and metallo-beta-lactamase producing multi drug resistant gram- negative bacteria from urinary isolates. Indian J Med Microbiol 2013;31:420-1.  Back to cited text no. 5
    
6.
Performance Standards for Antimicrobial Susceptibility Testing, 23 rd Informational Supplement. Wayne: CLSI; 2013. Clinical and Laboratory Standards Institute.  Back to cited text no. 6
    
7.
Gupta V, Yadav A, Joshi RM. Antibiotic resistance pattern in uropathogens. Indian J Med Microbiol 2002;20:96-8.  Back to cited text no. 7
[PUBMED]  Medknow Journal  
8.
Dash M, Padhi S, Mohanty I, Panda P, Parida B. Antimicrobial resistance in pathogens causing urinary tract infections in a rural community of Odisha, India. J Family Community Med 2013;20:20-6.  Back to cited text no. 8
    
9.
Prakash D, Saxena RS. Distribution and antimicrobial susceptibility pattern of bacterial pathogens causing urinary tract infection in urban community of Meerut city, India. ISRN Microbiol [749629] 2013 Sept; [13 p]. Available from: http://dx.doi.org/10.1155/2013/749629 [Last accessed on 2014 Sep 15].  Back to cited text no. 9
    
10.
Sharieff VA, Shenoy MS, Yadav T, MR. The antibiotic susceptibility pattern of uropathogenic Escherichia coli with special reference to the fluoroquinolones. J Clin Diagn Res 2013;7:1027-30.  Back to cited text no. 10
    
11.
Mukherjee M, Basu S, Mukherjee SK, Majumer M. Multidrug resistance and extended spectrum beta lactamase production in uropathogenic E. coli which were isolated from hospitalized patients in Kolkata, Indian. J Clin Diagn Res 2013;7:449-53.  Back to cited text no. 11
    
12.
Niranjan V, Malini A. Antimicrobial resistance pattern in Escherichia coli causing urinary tract infection among inpatients. Indian J Med Res 2014;139:945-8.  Back to cited text no. 12
[PUBMED]  Medknow Journal  

Top
Correspondence Address:
Nishat Hussain Ahmed
Department of Laboratory Medicine, Delhi State Cancer Institute, Delhi
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0974-777X.161742

Rights and Permissions



 
 
    Tables

  [Table 1], [Table 2]



 

Top
  
 
  Search
 
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Email Alert *
    Add to My List *
* Registration required (free)  


    Abstract
   Introduction
   Microbiology Report
   Conclusion
    References
    Article Tables

 Article Access Statistics
    Viewed2519    
    Printed40    
    Emailed0    
    PDF Downloaded24    
    Comments [Add]    

Recommend this journal

Sitemap | What's New | Feedback | Copyright and Disclaimer | Contact Us
2008 Journal of Global Infectious Diseases | Published by Wolters Kluwer - Medknow
Online since 10th December, 2008